FDA approves migraine drug from New Haven-based company Biohaven

The Food and Drug Administration has approved a migraine drug from New Haven-based company Biohaven.

News 12 Staff

May 29, 2021, 3:03 PM

Updated 1,085 days ago

Share:

The Food and Drug Administration has approved a migraine drug from New Haven-based company Biohaven.
Nurtec is the first and only migraine medication for acute and preventative treatment.
In a clinical trial, the drug reduced migraine days by 30% after around a week of patients taking it every other day.
Patients saw a 50% reduction a few months following taking the medicine.


More from News 12